MAZOR Surgical Robotics Ltd. announced that it has received American FDA (US Food and Drug Administration) approval for its integration of three-dimensional imaging capabilities for its Renaissance System, a new generation surgical robot. The Renaissance System replaces the SpineAssist System which has been marketed by the Company for the past several years.
